Back CASE STUDY

NHS Scotland

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam ac pellentesque nulla, ut tincidunt quam. Nullam vel tempor nibh. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam ac pellentesque nulla, ut tincidunt quam. Nullam vel tempor nibh.

About

Genomics England is the main pillar of the Government’s strategy to sequence 500k human genomes, deliver genomic medicine to the NHS and enhance UK research in genomics.

The Challenge

Traditional methods for managing the quality and consistency of data were failing, with teams becoming frustrated and overwhelmed due to the scale of the project.

How We Helped

  • Reduced irregularities and time to specify datasets
  • Improved knowledge sharing across teams
  • Improved data quality by setting standards for data entry
  • Cut time to develop and update their platform

customer

Genomics England

headquarters

London, United Kingdom

industry

Health Services

company size

XXXXXX

customer since

XXXX
Download Fact Sheet

Download Fact Sheet

Please fill in the following details to download the fact sheet.

Cancel

What they said

“When we started our work on the 100k Genomes Project, the complexity of managing data across so many different sites made it clear that our traditional methods for managing data definitions and processes were not going to work. METADATAWORKS have helped to ensure consistent and standardised data quality and processes for the 100,000 Genomes Project, supporting genomic analysis for participants.”
AMANDA O’NEIL
AMANDA O’NEIL HEAD OF CLINICAL DATA, GENOMICS ENGLAND
Want to find out more?
lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut tempus nulla sed arcu mattis accumsan. Curabitur nunc ex, porttitor sed feugiat sit amet, tincidunt ac urna.
Book a Demo

We use Cookies

We use tools, such as cookies, to enable essential services and functionality on our site and to collect data on how visitors interact with our site, products and services. By opting in or continuing to use this site, you agree to our use of these tools for advertising and analytics.